Cargando…
Antiviral therapy in neonatal cholestatic cytomegalovirus hepatitis
BACKGROUND: Neonatal hepatitis refers to a heterogeneous group of disorders, caused by many factors including cytomegalovirus infection, revealing similar morphologic changes in the liver of an infant less than 3 months of age. Approximately 40% of cholestasis in infants is due to neonatal hepatitis...
Autores principales: | Ozkan, Tanju Basarir, Mistik, Resit, Dikici, Bunyamin, Nazlioglu, Hülya Ozturk |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1847446/ https://www.ncbi.nlm.nih.gov/pubmed/17355631 http://dx.doi.org/10.1186/1471-230X-7-9 |
Ejemplares similares
-
Acquired Generalized Lipodystrophy Associated with Autoimmune Hepatitis and Low Serum C4 Level
por: Eren, Erdal, et al.
Publicado: (2010) -
High Rate of Cytomegalovirus Detection in Cholestatic Preterm Infants
por: Teng, Jonas, et al.
Publicado: (2021) -
Perianal mantle cell lymphoma mimicking an external thrombosed hemorrhoid: a case report
por: Gulcu, Baris, et al.
Publicado: (2014) -
Multichannel Intraluminal Impedance and pH Monitoring are Complementary Methods in the Diagnosis of Gastroesophageal Reflux Disease in Children
por: Altay, Derya, et al.
Publicado: (2022) -
Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: does interferon therapy prevent from osteoporosis?
por: Gur, Ali, et al.
Publicado: (2005)